-
Technology
-
Product
-
-
Company
Innovation · Anticoagulation Excellence
Heparin Precision:
Less is True Balance
Advanced lyophilized heparin technology — ultra-low concentration (<15 IU/mL) without compensation strategies. Preserves sample integrity, electrolyte accuracy, and delivers reliable anticoagulation through superior processing, not excess additive.
The Fundamental Challenge
Heparin: Essential Yet Demanding Precision
Heparin activates antithrombin III to prevent clotting, but its strong negative charge binds positively charged electrolytes — sodium (Na⁺), potassium (K⁺), and especially ionized calcium (Ca²⁺). Excessive heparin concentration introduces clinically significant bias, while inadequate anticoagulation leads to microclots that compromise analysis and damage blood gas analyzers. The challenge is not simply “adding more heparin”, but achieving reliable anticoagulation with minimal mass through superior manufacturing.
Global Standards: IFCC & CLSI Recommendations
Leading clinical chemistry organizations have established clear limits for heparin interference:
• IFCC (2018): “A final concentration of sodium or lithium heparin of 15 IU/mL blood or less should be used when measuring ionized calcium alongside blood gases.”
• CLSI C46-A2, Section 5.2.5: “For combined blood gas/electrolyte analysis, syringes should provide a final heparin concentration of no more than about 20 IU/mL blood … special heparin preparations are preferable.”
• Higher heparin concentrations (≥50 IU/mL) cause a reduction of ionized calcium by 0.15–0.19 mmol/L — a magnitude that alters clinical decisions, especially in critical care.
References: IFCC Point of Care Testing document (2018); CLSI C46-A2 (2009); van Berkel M, Scharnhorst V. Clin Chem Lab Med 2011;49:249–252.
The "Compensation" Pitfall
Why Electrolyte Compensation Falls Short
When heparin concentration is high, manufacturers often add extra calcium (“calcium-balanced heparin”) or other electrolytes to offset binding — a strategy known as compensation. However, this approach is fundamentally flawed because it assumes every patient has normal electrolyte levels. In reality, ICU, emergency, and surgical patients frequently present with abnormal sodium, potassium, or calcium. Compensation introduces unpredictable bias: patients with low baseline calcium will show falsely elevated readings, while those with normal levels still experience interference from the excess heparin itself.
Heparin concentration
Ionized calcium reduction
Clinical relevance
< 15 IU/mL (optimal)
~0.03 mmol/L
Negligible, no clinical impact
50 IU/mL
~0.15 mmol/L
Significant bias, affects therapy decisions
100 IU/mL
~0.19+ mmol/L
Unacceptable, may mask hypocalcemia
Beyond calcium: sodium and potassium are also affected. Heparin’s negative charge binds Na⁺ and K⁺ as well, potentially lowering measured sodium and potassium. Simultaneously, excessive mixing required for high-dose heparin increases hemolysis risk, which falsely elevates potassium (intracellular K⁺ is ~30× higher than plasma). True accuracy demands minimal heparin — not compensated heparin.
MeterOmega Core Technology
Lyophilized Molecular Heparin: Processing Defines Performance
Not all heparin is equal. The manufacturing process — drying method, uniformity, oxidation prevention — determines both anticoagulation efficacy and electrolyte interference. Our proprietary lyophilization achieves what conventional methods cannot: maximal activity with minimal mass.
Vacuum Freeze-Drying (Lyophilization)
Traditional approaches rely on liquid spraying followed by air-drying or oven-drying, which exposes heparin to oxygen and heat — leading to partial oxidation, reduced activity, and non‑uniform distribution. To compensate for degraded activity, manufacturers increase the total heparin load, perpetuating the cycle of interference.
MeterOmega’s advanced lyophilization: Heparin is frozen at ultra-low temperatures under vacuum; ice sublimates directly to vapor, leaving a highly porous, instantly soluble structure without thermal or oxidative damage. The result:
✓ Molecular‑level uniformity on the inner surface
✓ Final concentration ≤15 IU/mL — meeting IFCC/CLSI optimal limit
✓ Instant dissolution upon blood contact; no mixing required
✓ Long-term stability without potency loss
True Ionic Balance — No Compensation Artifacts
With ultra-low heparin (<15 IU/mL), binding of calcium, sodium, and potassium is minimal (<0.03 mmol/L for Ca²⁺, and proportionally low for Na⁺/K⁺). This eliminates the need for calcium titration or electrolyte compensation — avoiding the unpredictable biases that arise when a “one‑size‑fits‑all” compensation is applied to heterogeneous patient populations.
“The lowest effective heparin concentration preserves the original patient sample while providing safe, complete anticoagulation.”
— Aligned with IFCC recommendation: final heparin concentration ≤15 IU/mL for combined blood gas/electrolyte panels.
Processing Integrity: Why Drying Method Matters
Air-dried or oven-dried heparin inevitably undergoes oxidation, reducing its specific activity. To achieve reliable anticoagulation, manufacturers must load 3–5 times the theoretical required amount — leading to electrolyte interference, dilutional effects (when liquid heparin is used), and the need for “balanced” formulations that introduce additional bias. MeterOmega’s vacuum lyophilization preserves heparin’s native molecular structure, delivering full antithrombin activation at a fraction of the conventional mass. This is why our syringes require no complex mixing and produce no hemolysis from vigorous handling — a critical advantage noted in CLSI guidelines on preanalytical errors (C46-A2, Section 5.3.4).
How Heparin Processing Affects Clinical Performance
MeterOmega Vacuum Lyophilization
Independent evidence confirms: Even syringes with “electrolyte-balanced” claims introduce a mean bias of −4.4% for ionized calcium and −2.4% for sodium when evaluated against non‑heparinized blood (van Berkel & Scharnhorst, 2011). Only heparin concentrations ≤15 IU/mL without compensatory additives achieve true agreement. MeterOmega’s lyophilized heparin meets this stringent requirement while maintaining full anticoagulation efficacy.
Beyond Calcium: Sodium & Potassium
Comprehensive Electrolyte Preservation
While ionized calcium receives the most attention, heparin’s negative charge also binds sodium and potassium. This effect, although proportionally smaller, can still push results outside total allowable error limits — especially in patients with borderline values. Moreover, conventional syringes often require vigorous mixing to dissolve heparin, leading to hemolysis (rupture of red blood cells). Since intracellular potassium is roughly 30 times higher than plasma potassium, even minimal hemolysis falsely elevates potassium, potentially triggering inappropriate treatment.
MeterOmega’s lyophilized heparin dissolves instantly during blood filling — no post-collection mixing, no hemolysis, no artifactual potassium rise. Sodium and potassium remain at true patient values, and calcium binding is negligible.
Heparin Impact on Key Electrolytes
Electrolyte
Effect of high heparin (≥50 IU/mL)
MeterOmega (<15 IU/mL)
Ionized Calcium
↓ 0.15–0.19 mmol/L (clinical bias)
↓ ≤0.03 mmol/L (negligible)
Sodium
↓ 1–3 mmol/L (depending on heparin load)
No significant change
Potassium
Variable: direct binding lowers K⁺, but hemolysis from mixing raises K⁺ — unpredictable net effect
True value preserved; no mixing = no hemolysis
The combination of ultra-low heparin and instant dissolution eliminates the two main preanalytical errors: electrolyte binding and hemolysis-induced potassium shifts.
Total Solution Approach
Precision from Collection to Hemostasis
MeterOmega’s heparin technology is embedded across our arterial blood gas samplers — SyringeABG™, CapillaryABG™, and VETillaryABG™ — ensuring that the first step in the testing pathway does not compromise results. Combined with our hemostasis compressors (Crystal-Hemostop™, FEMO-SUPERBOWL™), we deliver complete vascular access solutions.
SyringeABG™ · <15 IU/mL lyo‑heparin
CapillaryABG™ · flow‑valve microsampling
Crystal-Hemostop™ · radial compression
FEMO-SUPERBOWL™ · femoral hemostasis
Experience True Sample Integrity
Ultra-low heparin, uncompromised anticoagulation — for accurate blood gases, electrolytes, and lactate.
Trusted in over 100 markets worldwide.
MeterOmega Medical Wuhan LTD
Address: NO.23-1-3 Gezhouba Suncity, GaoXin 4th road, East Lake development zone, Wuhan, China.
Tel: +86 (0) 27 6552 4498
Email: info@meteromega.com
Website: www.meteromega.com.cn
Hubei MeterOmega Technology LTD.
1F&2F, Building 3, Biomedical industrial Park, Jianqiu 5th Road, Duodao District, 448000, Jingmen City, Hubei Province, PEOPLE'S REPUBLIC OF CHINA
METER OMEGA CO., LTD.
Address: 1/126 Venis Di Iris, Soi Vatcharapol2/7, Tharaeng, Bangken Dist, Bangkok,10220,Thailand
Tel: +66962837333